Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Mato, M. Nakayama, T. Nakaya, H. Yamasawa, M. Bando, Y. Sugiyama (Shimotsuke, Japan). Process of pulmonary eosinophilia induced by intratracheal administration of Interleukin-33. Eur Respir J 2014; 44: Suppl. 58, 854

Member's Comments

No comment yet.

Related content which might interest you: Immunoaging augments sensitivity to cigarette smoke-induced COPD Source: International Congress 2014 – Effect of cigarette smoke on cell behaviour: cell biology, signalling and senescence Year: 2014 The U-BIOPRED severe asthma study: Immunopathological characterisation Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 LATE-BREAKING ABSTRACT: Airway remodelling induced by ADAM33 is reversible Source: International Congress 2014 – COPD: points to ponder Year: 2014 Characterisation of a steroid-insensitive severe asthma model Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Neutrophil degranulation responses in exacerbators and non-exacerbators of COPD Source: International Congress 2014 – Translational studies in COPD Year: 2014 Systemic characterization of macrophage phenotypes in allergic airway inflammation Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation Year: 2014 25-hydroxyvitamin D promotes the long-term effects of specific immunotherapy (SIT) in allergic airway inflammation in mice Source: International Congress 2014 – Animal models: asthma, COPD and beyond Year: 2014 Multi-analyte profiling of inflammatory markers in COPD sputum Source: International Congress 2014 – Translational studies in COPD Year: 2014 Proteomic investigation of pulmonary sarcoidosis Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 Adjuvant-free mouse model of allergic asthma Source: International Congress 2014 – Asthma: clinical problems Year: 2014 Association between airway inflammation, airway remodelling and physiological changes in asthma Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 Different roles for PI3Kgamma and δ in asthma Source: International Congress 2014 – Animal models: asthma, COPD and beyond Year: 2014 Acute markers of neutrophilic lung infiltration in the non-human primate LPS model Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Inflammation in COPD patients before and after roflumilast treatment Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014 Omalizumab prevents smooth muscle cell growth induced by asthmatic serum Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 Cigarette smoke-induced iBALT mediates macrophage activation in a B cell-dependent manner in COPD Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases Year: 2014 Modulation of neutrophil functionalities by indacaterol and their relevance for chronic lung diseases Source: International Congress 2014 – Translational studies in COPD Year: 2014 Serum periostin in obstructive airways disease: Range, relationships and response to corticosteroid Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 Effects of aerobic training on perivascular inflammation and on vascular activation in a model of asthma Source: International Congress 2014 – Animal models: asthma, COPD and beyond Year: 2014 The airway microbiota is significantly altered in subjects with eosinophilic asthma Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014